ProxyBio’s organoid platform allows for the high-throughput feature-rich investigation of physiologically relevant systems and translation of results through artificial intelligence for drug discovery or personalized medicine.

Precision anti-infective technology focused on a microbiome sparing strategy. We target Clostridioides difficile infection (CDI), an antibiotic-associated infectious diarrheal disease, through oral delivery of a targeted Antisense Oligonucleotide.

UArizona researchers have created an AI powered data-driven tool to forecast a personalized due date window for expectant mothers utilizing data from commonly worn personal devices like smart rings at various periods in gestation.

Senfina offers in vivo whole life drug discovery services for aging and age-related diseases based on a multi-feature high-throughput imaging platform using C. elegans as a model organism.

Innovations in healthcare are reshaping how we diagnose gynecologic conditions like endometrial cancer, endometriosis and adenomyosis. Our groundbreaking approach focuses on non-invasive sampling coupled with advanced biomarker analysis for early detection, especially among underserved populations. By leveraging integrated technologies, we aim to revolutionize women’s health, offering timely diagnoses, improving outcomes, and ultimately saving lives. Join us in our mission to make early detection of gynecologic conditions accessible to all women, regardless of their background or resources.

Many cancer drugs suffer from severe adverse effects due to acute high exposure and inadequate distribution to tumors. This technology provides a vehicle for the preferred delivery of existing and approved drugs to tumor environments and local release of the active agent, thereby focusing exposure to tissues in need and reducing unwanted side effects.

Stratofly Research seeks to deploy autonomous constellations of our patent-pending altitude-controlled high-altitude balloons (HABs) to collect higher fidelity in-situ atmospheric weather data in data-sparse areas such as over oceans, to improve weather forecasting.

Two of the HABs we manufacture do not require a lighter-than-air, reducing cost and complexity. Altitude-controlled HABs can autonomously adjust altitude to “ride” opposing winds at different altitudes for station-keeping over regions of interest and performing trajectory maneuvers.

With a 10x cost savings compared with current larger altitude-controlled HABs, these small low-cost HABs allow customers to deploy constellations of smaller payloads in the stratosphere, rather than one primary payload.

Aquaculture is the fastest growing food production sector in the world yet suffers 10% annual losses due to diseases (that’s ~$25 billion lost). Tools for control of these diseases are insufficient or too expensive. Efficacious and inexpensive solutions to address aquaculture disease are an industry priority. Our viral vector platform can be a solution – flexible and customizable to address finfish and crustacean diseases. It can be delivered orally to lower cost and make it more universally applicable to the industry.